The global antithrombin market revenue is expected to register a moderate CAGR over the forecast period. Increasing prevalence of blood clotting disorders across the globe is expected to drive the growth of the market over the forecast period. In addition, companies focusing on use of antithrombin in combination with heparin, increasing number of product approval are some other factors expected to drive growth of the market over the forecast period.

The global antithrombin market report has been segmented on the basis of application, source, form, and region.

On the basis of application, the target market is segmented based on therapeutics, diagnostics, and research. The therapeutic segment accounted for major revenue share of the market over the forecast period as compared to that of other segments.

On the basis of source, the global antithrombin market is segmented based on human, goat milk, and other. The goat milk segment accounted for major revenue share and is expected to maintain its dominance over the forecast period.

Request for the Sample Report Here: https://marketresearch.biz/report/antithrombin-market/request-sample/

Regional segmentation includes North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major revenue share and is expected to maintain its dominance over the forecast period. Asia Pacific region is expected to witness rapid growth rate over the forecast period. Countries like China and India is expected to support the growth of the market in Asia Pacific, owing to the increasing the prevalence of coagulation disorders in these countries over the forecast period. Moreover, improving healthcare infrastructure and rising healthcare expenditure are other factors expected to support the growth of the market in the region over the forecast period.

Some prominent players in the global antithrombin market are Grifols, Shire Plc., rEVO Biologics Inc., CSL Limited, Kedrion S.p.A, Lee Bisolutions, Scripps Laboratories Inc., GTC Biotherapeutics, Inc., Green Cross Corp., and BDI Pharma

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: